JAK inhibitors and other oral immunology drugs on BlueMedicare Premier Rx (S5795-002)
Rinvoq, Xeljanz, Olumiant and Otezla, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Arkansas
- Premium
- $181.20/month
- Deductible
- None
3 of 5 JAK inhibitors are covered on this plan. All 3 require prior authorization.
2 aren't on the formulary (Olumiant and Otezla).
- from $2,120.06Tier 5
- from $1,459.21Tier 5
- $2,285.97Tier 5
Not on the formulary
Olumiant, Otezla
Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.